Difference between revisions of "Research:MRNA vaccine"

From TermiKnowledge
Jump to navigation Jump to search
(Created page with "== Research == === Spelling variants === ===Synonyms=== * ===Definition/description=== Source: ===Examples=== '''1)''' Source: === Collocations === * ===Keyness=== ===No...")
 
(filled out Research section)
Line 6: Line 6:
*
*
===Definition/description===
===Definition/description===
Source:
In addition, the induction of an effective immune response requires stimulation of the innate immune system by the mRNA vaccine.
 
Source: https://doi.org/10.3389/fimmu.2018.01963
 
These results indicate that non-replicating mRNA vaccines potently induce an immunological repertoire associated with the generation of high magnitude long-lived antibodies.
 
Source: https://doi.org/10.3389/fimmu.2018.01963


===Examples===
===Examples===
'''1)'''  
'''1)''' Moderna reports that mRNA-1273 is an mRNA vaccine targeting a prefusion-stabilized form of the S protein associated with SARS-CoV-2, which was selected by Moderna in collaboration with investigators at the NIAID Vaccine Research Center.


Source:
Source: https://doi.org/10.1021/acscentsci.0c00272


=== Collocations ===
=== Collocations ===
* manufacture ~
* engineer ~
* optimize ~
* formulate ~
* administer ~
* deliver ~
* employ ~
* compose ~
* test ~
* ~ protect
* ~ feature
* ~ offer
* ~ induce
* ~ target
* effective ~
* potent ~
* conventional ~
*
*
===Keyness===
===Keyness===
> 1000
===Note===
===Note===

Revision as of 20:34, 14 January 2022

Research

Spelling variants

Synonyms

Definition/description

In addition, the induction of an effective immune response requires stimulation of the innate immune system by the mRNA vaccine.

Source: https://doi.org/10.3389/fimmu.2018.01963

These results indicate that non-replicating mRNA vaccines potently induce an immunological repertoire associated with the generation of high magnitude long-lived antibodies.

Source: https://doi.org/10.3389/fimmu.2018.01963

Examples

1) Moderna reports that mRNA-1273 is an mRNA vaccine targeting a prefusion-stabilized form of the S protein associated with SARS-CoV-2, which was selected by Moderna in collaboration with investigators at the NIAID Vaccine Research Center.

Source: https://doi.org/10.1021/acscentsci.0c00272

Collocations

  • manufacture ~
  • engineer ~
  • optimize ~
  • formulate ~
  • administer ~
  • deliver ~
  • employ ~
  • compose ~
  • test ~
  • ~ protect
  • ~ feature
  • ~ offer
  • ~ induce
  • ~ target
  • effective ~
  • potent ~
  • conventional ~

Keyness

> 1000

Note